Location: Dublin
Date:
Event description: BioEquity Europe 2023 gathers decision makers from around the world to workshops and panels,and a variety of networking opportunities, all making this event an unrivalled forum for companies across the biotech value chain to meet and do business. Novotech announced at JPMorgan this year that it had acquired EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. Our Novotech experts will be at BioEquity Europe 2023 to meet and share the benefits of Novotech’s recently expanded operations in Europe.
Schedule a meeting with our attendees
Meet Our Team
Novotech
David Chia
Novotech
Senior Business Development Manager
Plus experts from our China, Drug Development, and global Commercial teams.